Items per page
1 - 50 of 50
Title Published in Access level OA Policy Year Views Downloads
Identification of host cell surface proteins inhibiting furin dependent proteolytic processing of viral glycoproteinsScientific reports
accessLevelPublic
2025 40 12
Harnessing host enhancers of SARS-CoV-2 entry as novel targets for antiviral therapyAntiviral research
accessLevelPublic
2024 149 150
A clinical protocol for a German birth cohort study of the Maturation of Immunity Against respiratory viral Infections (MIAI)Frontiers in immunology
accessLevelPublic
2024 107 107
Identification of a short sequence motif in the influenza A virus pathogenicity factor PB1-F2 required for inhibition of human NLRP3Journal of virology
accessLevelPublic
2024 247 136
Influenza A virus infection alters the resistance profile of gut microbiota to clinically relevant antibioticsMicrobiology spectrum
accessLevelPublic
2023 164 106
Influenza A virus exploits transferrin receptor recycling to enter host cellsProceedings of the National Academy of Sciences of the United States of America
accessLevelPublic
2023 358 264
Wnt-Independent SARS-CoV-2 Infection in Pulmonary Epithelial CellsMicrobiology spectrum
accessLevelPublic
2023 184 107
Silent neonatal influenza A virus infection primes systemic antimicrobial immunityFrontiers in immunology
accessLevelPublic
2023 391 99
A quantitative model for virus uncoating predicts influenza A infectivityCell reports
accessLevelPublic
2023 178 48
Optimizing the live attenuated influenza A vaccine backbone for high-risk patient groupsJournal of virology
accessLevelPublic
2022 232 256
A single respiratory tract infection early in life reroutes healthy microbiome development and affects adult metabolism in a preclinical animal modelnpj biofilms and microbiomes
accessLevelPublic
2022 247 137
Visualization of respiratory commensal bacteria in context of their natural host environmentFrontiers in Microbiology
accessLevelPublic
2021 279 158
Influenza A viruses balance ER stress with host protein synthesis shutoffProceedings of the National Academy of Sciences
accessLevelRestricted
2021 446 11
Influenza A viruses limit NLRP3-NEK7-complex formation and pyroptosis in human macrophagesEMBO Reports
accessLevelRestricted
2020 387 0
Microbiome disturbance and resilience dynamics of the upper respiratory tract during influenza A virus infectionNature Communications
accessLevelPublic
2020 535 185
Respiratory tissue-associated commensal bacteria offer therapeutic potential against pneumococcal colonizationeLife
accessLevelPublic
2020 449 211
Ménage à trois: virus, host, and microbiota in experimental infection modelsTrends in Microbiology
accessLevelPublic
2019 439 580
Influenza A Virus Genetic Tools: From Clinical Sample to Molecular CloneInfluenza Virus. Methods in Molecular Biology
accessLevelRestricted
2018 465 4
Phosphoproteomic-based kinase profiling early in influenza virus infection identifies GRK2 as antiviral drug targetNature Communications
accessLevelPublic
2018 488 239
Overcoming the neonatal limitations of inducing germinal centers through liposome-based adjuvants including c-type lectin agonists trehalose dibehenate or curdlanFrontiers in Immunology
accessLevelPublic
2018 495 482
H5N1 influenza A virus PB1-F2 relieves HAX-1-mediated restriction of avian virus polymerase PA in human lung cellsJournal of Virology
accessLevelPublic
2018 325 168
Influenza A virus infection impacts systemic microbiota dynamics and causes quantitative enteric dysbiosisMicrobiome
accessLevelPublic
2018 381 142
RIG-I Signaling Is Critical for Efficient Polyfunctional T Cell Responses during Influenza Virus InfectionPLOS pathogens
accessLevelPublic
2016 626 296
The nucleoprotein of newly emerged H7N9 influenza A virus harbors a unique motif conferring resistance to antiviral human MxAJournal of virology
accessLevelRestricted
2015 700 2
Human dendritic cell response signatures distinguish 1918, pandemic and seasonal H1N1 influenza virusesJournal of virology
accessLevelRestricted
2015 661 3
Evidence for a Novel Mechanism of Influenza Virus-Induced Type I Interferon Expression by a Defective RNA-Encoded ProteinPLOS pathogens
accessLevelPublic
2015 731 284
Infectious disease. Life-threatening influenza and impaired interferon amplification in human IRF7 deficiencyScience
accessLevelRestricted
2015 796 2
The origin of the PB1 segment of swine influenza A virus subtype H1N2 determines viral pathogenicity in miceVirus research
accessLevelPublic
2014 553 338
Avian influenza A H10N8--a virus on the verge?Lancet
accessLevelPublic
2014 499 552
A single amino acid substitution in the novel H7N9 influenza A virus NS1 protein increases CPSF30 binding and virulenceJournal of virology
accessLevelPublic
2014 597 400
Divergent H7 immunogens offer protection from H7N9 virus challengeJournal of virology
accessLevelRestricted
2014 716 0
RIG-I detects mRNA of intracellular Salmonella enterica serovar Typhimurium during bacterial infectionMBio
accessLevelPublic
2014 735 232
Inhibition of p38 mitogen-activated protein kinase impairs influenza virus-induced primary and secondary host gene responses and protects mice from lethal H5N1 infectionThe Journal of biological chemistry
accessLevelPublic
2014 731 273
17β-estradiol protects primary macrophages against HIV infection through induction of interferon-alphaViral immunology
accessLevelPublic
2014 590 247
Highly pathogenic influenza viruses inhibit inflammatory response in monocytes via activation of rar-related orphan receptor RORαJournal of innate immunity
accessLevelRestricted
2013 576 0
Influenza A(H7N9) virus gains neuraminidase inhibitor resistance without loss of in vivo virulence or transmissibilityNature communications
accessLevelPublic
2013 614 287
Influenza virus sequence feature variant type analysis: evidence of a role for NS1 in influenza virus host range restrictionJournal of virology
accessLevelPublic
2012 513 215
Host modulators of H1N1 cytopathogenicityPloS one
accessLevelPublic
2012 579 1,364
Inhibition of pyrimidine synthesis reverses viral virulence factor-mediated block of mRNA nuclear exportThe Journal of cell biology
accessLevelRestricted
2012 547 0
Cross-presenting CD103+ dendritic cells are protected from influenza virus infectionThe Journal of clinical investigation
accessLevelRestricted
2012 501 0
The influenza virus protein PB1-F2 inhibits the induction of type I interferon at the level of the MAVS adaptor proteinPLOS pathogens
accessLevelPublic
2011 678 291
Differential contribution of PB1-F2 to the virulence of highly pathogenic H5N1 influenza A virus in mammalian and avian speciesPLOS pathogens
accessLevelPublic
2011 576 411
Chemical inhibition of RNA viruses reveals REDD1 as a host defense factorNature chemical biology
accessLevelPublic
2011 594 266
H5N1 virus activates signaling pathways in human endothelial cells resulting in a specific imbalanced inflammatory responseThe Journal of immunology
accessLevelRestricted
2011 512 0
Inefficient control of host gene expression by the 2009 pandemic H1N1 influenza A virus NS1 proteinJournal of virology
accessLevelPublic
2010 557 329
Erk5 activation elicits a vasoprotective endothelial phenotype via induction of Kruppel-like factor 4 (KLF4)The Journal of biological chemistry
accessLevelRestricted
2010 530 0
NS-based live attenuated H1N1 pandemic vaccines protect mice and ferretsVaccine
accessLevelPublic
2010 635 751
PB1-F2 expression by the 2009 pandemic H1N1 influenza virus has minimal impact on virulence in animal modelsJournal of virology
accessLevelPublic
2010 629 272
Evasion of innate and adaptive immune responses by influenza A virusCellular microbiology
accessLevelPublic
2010 621 338
Essential impact of NF-kappaB signaling on the H5N1 influenza A virus-induced transcriptomeThe Journal of immunology
accessLevelPublic
2009 593 707
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack